TOKYO — Asian travel companies are increasingly optimistic that recent breakthroughs in producing effective coronavirus vaccines will soon help the industry get back to normality — even though worries persist about a near-term resurgence of the pandemic and some officials suggest incentives to travel should be curbed.
While the travel industry in the region faces relatively faster pickups than other parts of the world, as latest airline data reveals, the resurgence of newly confirmed cases in Europe and the U.S. — even some countries in Asia — poses a challenge for the revival of cross-border trips anytime soon.
“Hopefully, with Pfizer’s news it will make mass production available to the world. … I’m sure, with our concerted efforts, we should be able to overcome this difficulty very quickly,” Jane Sun, CEO of online Chinese travel giant Trip.com Group, told Nikkei Asia in an interview last week.
Sun was referring to